Reacción #371

ord-5b8b8e8b9f444b0ba792e38397226bc2

Ecuación de reacción

FCCN1Cc2cnc(Cl)nc2O[C@H](c2ccccc2)C1
FCCN1Cc2cnc(Cl)nc2O[
COc1cc(N)ccc1-n1cnc(C)c1
COc1cc(N)ccc1-n1cnc(
COc1cc(Nc2ncc3c(n2)O[C@H](c2ccccc2)CN(CCF)C3)ccc1-n1cnc(C)c1
COc1cc(Nc2ncc3c(n2)O
Rendimiento 14.9%

Disolventes

Condiciones de reacción

Temperatura
100°CELSIUS

Procedimiento

3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline (0.118 g, 0.49 mmol), Palladium(II) acetate (9.19 mg, 0.04 mmol), 2-(Dicyclohexylphosphino)biphenyl (0.014 g, 0.04 mmol) and Cesium carbonate (0.00 µmol) were put in a 5 mL microwave vial and sealed and purged with argon. (R)-2-chloro-6-(2-fluoroethyl)-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepine (0.126 g, 0.41 mmol) in DME (5 mL) was added. The reaction mixture was run in the microwave at 100°C for 60 minutes. Reaction still not complete. Additional palladium(II)acetate and 2-(dicyclohexylphosphino)biphenyl (small spatula) and the reaction was run again in the microwave for 60 minutes. The reaction mixture was filtrated through celite, concentrated and purified by preparative chromatography. The productcontaining fractions were pooled, concentrated and partitioned between sat. NaHCO3 (aq) and dichloromethane. The organic layer was washed with brine, dried (NaSO4) and concentrated giving (R)-6-(2-fluoroethyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-phenyl-5,6,7,8-tetrahydropyrimido[5,4-f][1,4]oxazepin-2-amine (0.029 g, 14.93 %) as the product.

Fuente

750 AstraZeneca ELN dataset